Pharmaceutical Repackaging Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
-
Contract Value
Not provided
Codes & Classification
Solicitation Number
03826
NAICS
-
Classification Code
-
Additional Details
Documents4
The Washington State Department of Enterprise Services (Enterprise Services) has announced its intent to execute a Participating Addendum to the existing MMCAP Pharmaceutical Repackaging Contract. This procurement activity is designed to secure medication repackaging services that transform bulk-purchased medications or supplies into unit-dose packaging. The primary objectives of this initiative are to reduce overall medication costs, minimize pharmaceutical waste, support accurate dosing practices, and offer a cost-effective alternative to commercially available unit-dose products.
The scope of work under this addendum encompasses the repackaging of pharmaceuticals from bulk formats into unit-dose packaging, which is essential for healthcare providers seeking to optimize inventory management and ensure precise medication administration. By leveraging these services, participating entities can expect improved operational efficiency, enhanced patient safety through accurate dosing, and significant cost savings compared to purchasing pre-packaged unit-dose medications.
This opportunity is being managed by Enterprise Services for the State of Washington (State Code: WA), with the place of performance also located within Washington State. The procurement is classified under the identifier 03826. Interested parties should note that the notice was posted on August 31, 2026, with a response deadline of May 31, 2027. The procurement is being facilitated through the BIDMATCH_SLED platform, and further details can be accessed via the official notice URL: https://apps.des.wa.gov/DESContracts/Home/ContractSummary/03826.
While the notice does not specify set-aside requirements, procurement type, or special considerations, it is important for potential contractors to recognize that this addendum is tied to an existing MMCAP contract. As such, familiarity with MMCAP contract terms and experience in pharmaceutical repackaging for institutional or government clients may be advantageous.
No additional documents or attachments are currently provided with the notice. Contractors interested in this opportunity should monitor the provided URLs for updates and further instructions regarding the submission process.
In summary, this procurement seeks qualified providers capable of delivering reliable, cost-effective pharmaceutical repackaging services to support Washington State’s healthcare operations, with a focus on efficiency, waste reduction, and patient safety.